RELMADA THERAPEUTICS, INC. (RLMD) Common Stock, Shares Authorized 2012 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Relmada Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from 2012 to 2024.
  • Relmada Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending March 31, 2024 was 150 M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 150 M 0 0% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 150 M 0 0% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 150 M 0 0% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 150 M 0 0% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 150 M +100 M +200% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 150 M 0 0% Dec 31, 2022 10-K 2024-03-19
Q3 2022 150 M +100 M +200% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 150 M +100 M +200% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 50 M 0 0% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 150 M +100 M +200% Dec 31, 2021 10-K 2023-03-23
Q3 2021 50 M 0 0% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 50 M 0 0% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 50 M 0 0% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 50 M 0 0% Dec 31, 2020 10-K 2022-03-25
Q3 2020 50 M 0 0% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 50 M 0 0% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 50 M -150 M -75% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 50 M -50 M -50% Dec 31, 2019 10-K 2021-03-24
Q3 2019 50 M -50 M -50% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 50 M 0 0% Jun 30, 2019 10-K 2021-03-24
Q1 2019 200 M +100 M +100% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 100 M 0 0% Dec 31, 2018 10-Q 2019-02-13
Q3 2018 100 M 0 0% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 50 M -50 M -50% Jun 30, 2018 10-KT 2020-03-26
Q1 2018 100 M 0 0% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 100 M 0 0% Dec 31, 2017 10-Q 2018-02-12
Q3 2017 100 M 0 0% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 100 M 0 0% Jun 30, 2017 10-K 2018-09-28
Q1 2017 100 M 0 0% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 100 M 0 0% Dec 31, 2016 10-Q 2017-02-10
Q3 2016 100 M 0 0% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 100 M 0 0% Jun 30, 2016 10-K 2017-09-28
Q1 2016 100 M -400 M -80% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 100 M -400 M -80% Dec 31, 2015 10-Q 2016-02-05
Q3 2015 100 M -400 M -80% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 100 M 0 0% Jun 30, 2015 10-K 2016-09-09
Q1 2015 500 M -500 M -50% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 500 M 0 0% Dec 31, 2014 10-Q 2015-02-13
Q3 2014 500 M +410 M +456% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 100 M +10 M +11.1% Jun 30, 2014 10-K 2015-09-11
Q1 2014 1 B +910 M +1011% Mar 31, 2014 8-K 2014-05-27
Q4 2013 500 M -500 M -50% Dec 31, 2013 10-KT 2014-09-09
Q3 2013 90 M 0 0% Aug 31, 2013 10-Q 2014-04-15
Q2 2013 90 M May 31, 2013 10-Q 2013-07-12
Q1 2013 90 M Feb 28, 2013 10-Q 2013-05-03
Q4 2012 1 B Dec 31, 2012 8-K 2014-05-27
Q3 2012 90 M Aug 31, 2012 10-K 2013-12-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.